GLPwatch
Trials (2167)
Page 23 of 37.
- Investigate Safety, Tolerability and Pharmacokinetics for Single Doses of NNC9204-0530 Alone and in Combination With Liraglutide in Overweight to Obese But Otherwise Healthy Male Subjects
- Emulation of the SUMMIT Heart Failure Trial in Healthcare Claims Data
- Oral vs. Subcutaneous Semaglutide in Type 2 Diabetes Mellitus
- GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation in Monotherapy
- A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and at Least One Weight-Related Comorbidity
- The Effect of Glucagon-like-peptide 1 (GLP-1) Receptor Agonism on Diabetic Kidney Disease
- A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
- Treatment of Bile Acid Malabsorption With Liraglutide
- Efficacy and Safety of Lixisenatide in Patients With Type 2 Diabetes Mellitus Insufficiently Controlled by Metformin
- A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in the United Kingdom, as Part of Local Clinical Practice
- Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes
- The Effect of Semaglutide on Cardiovascular Markers and Liver Function
- To Evaluate the Effect of Liraglutide on Ambulatory Blood Pressure-A Pilot Study
- Effects of a GLP-1 Receptor Agonist on Functional Activation and Connectivity of the Brain
- A Study to Determine the Feasibility of Online Recruitment of People Using an Anti-Obesity Medication for Weight Loss
- SUSTAIN SWITCH: A Research Study to Compare Two Dose Schedules of Semaglutide Taken Once Weekly in People With Type 2 Diabetes
- Effects of Benaglutide on Weight and Gut Microbiota in Obese Patients
- Effects of Glucagon-like-Peptide-1 Analogues on Sexuality
- Efficacy and Safety of Semaglutide Versus Placebo on Cardiometabolic Profile in Patients With Schizophrenia With Metabolic Syndrome
- A Study of SRSD384 in Overweight or Obese Participants
- A Study on Safety, Pharmacokinetics and Pharmacodynamics of Lixisenatide in Pediatric Patients With Type 2 Diabetes Mellitus (T2DM)
- The Effect of Lixisenatide on the Effect of Pituitary Hormones
- Effect of Liraglutide on Glucose Profiles and Gastric Emptying in Subjects With Type 2 Diabetes
- The Effect of Soliqua on Glucose Variability in Type 2 Patients Among South Asians
- The Effect of Simple Basal Insulin Titration, Metformin Plus Liraglutide for Type 2 Diabetes With Very Elevated HbA1c - The SIMPLE Study
- Comparison of Two Liraglutide Formulations in Healthy Volunteers
- Glycaemic Control of Monthly LAPS-Exendin Versus Placebo in Subjects of Type 2 Diabetes
- Safety and Efficacy of Liraglutide in Combination With an OAD in Subjects With Type 2 Diabetes Insufficiently Controlled on OAD Alone
- A Research Study to Compare Blood Levels of Two Different Versions of Cagrilintide in Adults With Excess Body Weight
- The Effect of GLP-1 on Postprandial Glucagon Secretion Independent of The Gastric Emptying Rate
- A Study of Pharmacokinetic Comparison of Two Recombinant Exendin-4 Formulations in Chinese Healthy Male Subjects
- A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in Switzerland, as Part of Local Clinical Practice (SURE SWITZERLAND)
- Comparison of Exenatide vs. Biphasic Insulin Aspart 30 on Glucose Variability in Type 2 Diabetes
- A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Mexico, as Part of Local Clinical Practice
- A Research Study on How Well Semaglutide Works in Adolescents With Overweight or Obesity
- Trial of EXenatide in Acute Ischaemic Stroke
- Efficacy and Safety of Tirzepatide for Weight Management
- A Study of LY3457263 in Healthy Participants and Participants With Type 2 Diabetes
- A Research Study Looking at How Victoza® Works in People With Type 2 Diabetes in Iran, Followed in Local Clinical Routine
- LIPT - Liraglutide in Polycystic Ovary Syndrome
- Comparison of the Safety, Efficacy and Pharmacokinetics of DehydraTECH -CBD and DehydraTECH-GLP1 Agonists Alone or in Combination, in Overweight or Obese, Pre- and Type 2 Diabetic Participants
- Research Study to Investigate How Well Semaglutide Tablets Taken Once Daily Work in People Who Are Overweight or Living With Obesity (OASIS 1)
- Comparison of Lixisenatide Injected Prior to the Main Meal of the Day Versus Prior to Breakfast in Type 2 Diabetic Patients on Metformin
- The Effect of GLP-1 Receptor Agonist on Cerebral Blood Flow Velocity in Stroke
- A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Insulin Glargine Taken Daily With Insulin Aspart (COMBINE 3)
- Methodology Study To Examine 6-Week Food Intake With Liraglutide In Obese Subjects
- A Drug-Drug Interaction (DDI) Study of Orforglipron With Carbamazepine in Healthy Participants
- In-market Utilisation of Liraglutide Used for Weight Management in Europe
- A Research Study Comparing Wegovy to Other Weight Management Drugs in People Living With Obesity in America
- A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Spain, as Part of Local Clinical Practice
- Use of Exenatide and Pramlintide to Decrease Post-prandial Hyperglycemia
- A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in Germany, as Part of Local Clinical Practice (SURE GERMANY)
- Effect of Semaglutide on Embryo Quality in Overweight and Obese Patients Undergoing In Vitro Fertilization.
- Vitamin C and Liraglutide Effects on Hypoglycemia-induced Oxidative Stress, Inflammation and Endothelial Dysfunction in Type 1 Diabetes.
- The Effects of Tirzepatide in People With Overweight/Obesity and Coronary Artery Disease
- Effect of Weight Loss on Physical and Cardiac Performance in People With Obesity and Heart Failure
- A Study in Chinese People With Overweight or Obesity to Test How Different Doses of Survodutide Are Taken up in the Body
- Effect of Liraglutide on the Beta-cell Responsiveness in Subjects With Type 2 Diabetes Compared to a Healthy Control Group
- Research Study Comparing Different Tablets With the Study Medicine Semaglutide in Healthy Men
- Sleeve Gastrectomy vs. Lifestyle & Medications: Impact on BMI Trajectory and Target Attainment in a Matched Cohort Study